Does epclusa treat hep c?

Does Epclusa (sofosbuvir/velpatasvir) treat hepatitis C?

Yes. Epclusa is an antiviral medication approved to treat hepatitis C virus (HCV) infection. It contains sofosbuvir and velpatasvir, which work by blocking key steps in the HCV life cycle.[1]

What hepatitis C types and patient groups does it cover?

Epclusa is used for people with chronic hepatitis C and is prescribed across multiple HCV genotypes (it is a pan-genotypic regimen in the information available).[1] It is commonly used in combination treatment settings depending on a person’s treatment history and liver status.[1]

How is Epclusa usually taken?

Epclusa is typically taken once daily as a fixed-dose combination tablet of sofosbuvir/velpatasvir.[1]

Are there important cautions (like drug interactions) before using it?

Yes. Epclusa can have clinically significant drug interactions, so clinicians review current medications before starting therapy.[1]

What does a typical course look like?

Epclusa is usually prescribed as a time-limited course determined by the patient’s specific HCV situation (such as prior treatment and whether cirrhosis is present).[1]

Sources:
[1] https://www.drugs.com/epclusa.html